Bupropion HCL ER

Modification P00008 SPE2D223D0002 is issued to invoke option year 3 for Bupropion HCL ER National Contract.

Modification P00007 SPE2D223D0002 is issued in accordance with DoD Class Deviation 2025-O0003 and Class Deviation 2025-O0004 into subject solicitation.

Modification P00006 SPE2D223D0002 is issued to invoke option year 2 for Bupropion HCL ER National Contract.

Modification P00005 SPE2D223D0002 is issued to incorporate FAR 52.204-30 Federal Acquisition Supply Chain Security Act Orders into subject solicitation.

BUPROPION HCL ER NATIONAL CONTRACTS SOLICITATION

BUPROPION HCL ER NATIONAL CONTRACTS SOLICITATION

The Defense Logistics Agency is planning to issue a solicitation for a national requirements contract for Bupropion HCL ER Tablets. Procurement details follow.

Bupropion HCL ER 24H 150 MG tablets in 30, 90, and 500 count bottles; and 300 MG tablets in 30, 90, and 500 count bottles. This will be an unrestricted and fully open competitive acquisition. The contract will be a firm-fixed price, requirements type contract with a one year base and four one year options. A contract resulting from this solicitation will establish a national supply source, in accordance with FAR 52.216-21 (Requirements), to provide the .... Read More